IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY

被引：0
|
作者：
Pellegrino, Francesco
Falagario, Ugo G.
Knipper, Sophie
Martini, Alberto
Akre, Olof
Aly, Markus
Moschovas, Marcio C.
Bravi, Carlo A.
Tran, Joshua
Heiniger, Yasmin
von Kempis, Antonius
Schaffar, Robin
Carrieri, Giuseppe
Briganti, Alberto
Montorsi, Francesco
Rochat, Charles-Henry
Mottrie, Alexandre
Ahlering, Thomas E.
John, Hubert
Patel, Vipul
Graefen, Markus
Wiklund, Peter
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001009428.69695.82.02
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-02
引用
收藏
页码：E219 / E220
页数：2
相关论文
共 50 条
  • [31] DELAYED ANDROGEN DEPRIVATION THERAPY AT TIME OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH POSITIVE LYMPH NODES AFTER RADICAL PROSTATECTOMY
    Lodde, Michele
    Mian, Michael
    Naselli, Angelo
    Puppo, Paolo
    Lacombe, Louis
    Fradet, Yves
    ANTICANCER RESEARCH, 2010, 30 (04) : 1432 - 1432
  • [32] Identifying the optimal candidates for concomitant androgen-deprivation therapy among patients receiving metastasis-directed therapy for positive 68Ga-PSMA PET/CT for biochemical recurrent prostate cancer after radical prostatectomy
    Mazzone, E.
    Gandaglia, G.
    Stabile, A.
    Robesti, D.
    Necchi, A.
    Raggi, D.
    Marandino, L.
    Cirulli, G.
    Scuderi, S.
    Barletta, F.
    Pellegrino, A. A.
    De Angelis, M.
    Cucchiara, V.
    Rosiello, G.
    Sorce, G.
    Nocera, L.
    Pellegrino, F.
    Longoni, M.
    Scilipoti, P.
    Quarta, L.
    Gallina, A.
    Fossati, N.
    Montorsi, F.
    Briganti, A.
    EUROPEAN UROLOGY, 2023, 83
  • [33] Long-term outcome of detectable PSA levels after radical prostatectomy
    Ahlering, TE
    Skarecky, DW
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (02) : 163 - 166
  • [34] Long-term outcome of detectable PSA levels after radical prostatectomy
    T E Ahlering
    D W Skarecky
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 163 - 166
  • [35] Risk Stratification of Patients with Extraprostatic Extension and Negative Lymph Nodes at Radical Prostatectomy: Identifying Optimal Candidates for Adjuvant Therapy
    Eisenberg, Manuel S.
    Karnes, R. Jeffrey
    Kaushik, Dharam
    Rangel, Laureano
    Bergstralh, Eric J.
    Boorjian, Stephen A.
    JOURNAL OF UROLOGY, 2013, 190 (05): : 1735 - 1741
  • [36] ADJUVANT RADIATION-THERAPY IN PATIENTS WITH DETECTABLE PROSTATE SPECIFIC ANTIGEN FOLLOWING RADICAL PROSTATECTOMY
    LINK, P
    FREIHA, FS
    STAMEY, TA
    JOURNAL OF UROLOGY, 1991, 145 (03): : 532 - 534
  • [37] Adjuvant radiation therapy after radical prostatectomy
    Gerard, JP
    Clippe, S
    Ardiet, JM
    5TH MEDITERRANEAN CONGRESS OF UROLOGY, 1997, : 151 - 153
  • [38] Adjuvant radiation therapy after radical prostatectomy
    Duque Santana, V.
    Dominguez Rullan, J.
    Hervas Moron, A.
    Lopez-Campos, F.
    Vallejo Ocana, C.
    Valero Perena, M.
    Martin Martin, M.
    Sevillano Martinez, D.
    Garcia Fuentes, J. D.
    Sancho Garcia, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1181 - S1181
  • [39] Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: identifying men who benefit
    Gupta, Mohit
    Patel, Hiten D.
    Schwen, Zeyad P.
    Tran, Phuoc T.
    Partin, Alan W.
    BJU INTERNATIONAL, 2019, 123 (02) : 252 - 260
  • [40] Effects of androgen deprivation prior to radical prostatectomy in 375 patients
    Tunn, UW
    Acar, O
    Goldschmidt, AJW
    UROLOGIA INTERNATIONALIS, 1996, 56 : 6 - 12
12345